Chief Accounting Officer
Coherus Oncology, Inc. (CHRS)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Bryan McMichael is recorded as CFO and Chief Accounting Officer at Coherus Oncology, Inc. (CHRS). Coherus Oncology, Inc. reported in an 8-K filed August 8, 2024 that Bryan McMichael was appointed Chief Financial Officer, effective August 1, 2024. Coherus Oncology, Inc. reported in an 8-K filed December 11, 2023 that Bryan McMichael was appointed Interim Chief Financial Officer and Principal Financial Officer, effective December 8, 2023. Coherus Oncology, Inc. reported in an 8-K filed September 9, 2022 that Bryan McMichael was appointed Senior Vice President, Accounting, Corporate Controller and Principal Accounting Officer, effective September 7, 2022. Bryan McMichael has spoken on 8 earnings calls across 1 company, most recently for Coherus Oncology, Inc. on August 5, 2026.
“On August 7, 2024, the Company’s board of directors appointed Bryan McMichael, age 46, the Company’s current Interim Chief Financial Officer, Executive Vice President, Accounting, Corporate Controller, to serve as the Company’s Chief Financial Officer effective August 1, 2024.”
“The Board of Directors of the Company appointed Bryan McMichael, age 45, to serve as the Company's Interim Chief Financial Officer and Principal Financial Officer effective December 8, 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2022-09-07–present
Start not stated–present
Recorded roles and call appearances connecting this person to public companies.
CFO, Chief Accounting Officer
2022-09-07–present
Other people whose current roles at this company are on record from its filings.
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
